⌘K
Loading ticker…
As of 2026-08-24, Baxter International Inc. (BAX) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.9%, relative volume 0.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
BAX is in a stage 2 uptrend, week 4. Currently in a 14-day base; basing ADR 3.0% (broad 3.6%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 11.7% / 32.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
BAX is held by 46 ETFs as of May 2026. Top owner: VHT at 0.15% weight, $29M notional. Top 3 carry $70M.
Held by 140 ETFs · $1.7B across latest filings · largest weight 4.44% (PZLV).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.15% | $29M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.18% | $26M | −0.03 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.06% | $15M | — |
| SCHXSchwab U.S. Large-Cap ETF | 0.01% | $10M | — |
| VONV |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $6M |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $6M | — |
| RWL | 0.06% | $5M | — |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.03% | $5M | — |
| PZLV | 4.44% | $3M | — |
| VOOV | 0.03% | $2M | — |
Showing 10 of 46 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BAX Jan avg: 1.60% median: 2.55% win: 75% σ: 9.28% n: 4 2022-04-12 → 2026-07-31 | BAX Feb avg: 0.17% median: 3.63% win: 75% σ: 8.74% n: 4 2022-04-12 → 2026-07-31 | BAX Mar avg: -3.09% median: 0.36% win: 50% σ: 9.86% n: 4 2022-04-12 → 2026-07-31 | BAX Apr avg: -0.41% median: -5.54% win: 40% σ: 11.57% n: 5 2022-04-12 → 2026-07-31 | BAX May avg: -3.69% median: -2.15% win: 40% σ: 11.04% n: 5 2022-04-12 → 2026-07-31 | BAX Jun avg: 1.45% median: -0.72% win: 40% σ: 11.82% n: 5 2022-04-12 → 2026-07-31 | BAX Jul avg: -1.55% median: -0.72% win: 40% σ: 18.85% n: 5 2022-04-12 → 2026-07-31 | BAX Aug avg: 1.77% median: 1.94% win: 50% σ: 10.21% n: 4 2022-04-12 → 2026-07-31 (current) | BAX Sep avg: -5.25% median: -6.65% win: 25% σ: 3.61% n: 4 2022-04-12 → 2026-07-31 | BAX Oct avg: -9.51% median: -10.02% win: 25% σ: 8.75% n: 4 2022-04-12 → 2026-07-31 | BAX Nov avg: 2.79% median: 2.74% win: 75% σ: 6.95% n: 4 2022-04-12 → 2026-07-31 | BAX Dec avg: -3.55% median: -3.93% win: 50% σ: 9.72% n: 4 2022-04-12 → 2026-07-31 |